About this trial
In ICU, fluid challenge represents one of the cornerstones of hemodynamic care. However, fluid overload due to an excessive and/or inappropriate fluid administration could be associated with morbidity or mortality. Unfortunately, there is currently no continuous non-invasive devices to monitor fluid content at bedside. Bio reactance is a non-invasive, rapid and continuous technology developed in order to measure body fluid compartment. Monitoring devices functioning with such technology are promising to evaluate fluid overload in ICU.
Eligibility criteria
Qualifiers
Adult (Age >18 years old)
A suspected or confirmed infection
Persisting hypotension, despite adequate fluid resuscitation, requiring vasopressor to maintain a Mean Arterial Pressure (MAP) ≥ 65 mmHg
Lactate level > 2 mmol/l
Disqualifiers
Admission in ICU for more than 3 days
Refusal to participate
Moribund patients
Decision of therapeutic withdrawal
Trial design
Treatments tested in this trial
- Not listed